Literature DB >> 21789354

Dengue: clinical forms and risk groups in a high incidence city in the southeastern region of Brazil.

Ivana Macedo Cardoso1, Aline de Souza Areias Cabidelle, Patrícia de Castro E Leão Borges, Carolina Ferreira Lang, Fabrício Greco Calenti, Larissa de Oliveira Nogueira, Aloisio Falqueto, Crispim Cerutti Junior.   

Abstract

INTRODUCTION: The article describes the epidemiologic profile of dengue cases in Vitória, the capital of Espírito Santo, Brazil, from 2000 to 2009, aimed at identifying risk groups regarding the incidence and severity of the disease.
METHODS: Confirmed cases of dengue among city residents during ten years were classified as dengue fever, dengue hemorrhagic fever, dengue shock syndrome and dengue with complications, and analyzed according to sex, age, race-color and education.
RESULTS: The proportion of dengue cases was highest among women aged 20 to 29 years-old and similar between whites and blacks. A gradual decrease occurred in the percentage of dengue cases in the population aged 15 years-old or more, in the historical series of 10 years, and a growing increase in individuals less than 15 years-old, showing statistical significance. The fatality rate ranged from zero to 0.3% for all forms of dengue and from 0.2% to 18.2% for severe forms.
CONCLUSIONS: The profile of those affected by the disease in the municipality is similar to those affected in Brazil. The increasing number of cases in individuals under 15 years-old corroborates the results of recent studies in other Brazilian municipalities.

Entities:  

Mesh:

Year:  2011        PMID: 21789354     DOI: 10.1590/s0037-86822011005000044

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  11 in total

1.  The innate immune response following multivalent dengue vaccination and implications for protection against dengue challenge.

Authors:  Ruixue Hou; Lewis E Tomalin; Jessica Pintado Silva; Seunghee Kim-Schulze; Stephen S Whitehead; Ana Fernandez-Sesma; Anna P Durbin; Mayte Suárez-Fariñas
Journal:  JCI Insight       Date:  2022-06-08

Review 2.  Dengue vaccines: recent developments, ongoing challenges and current candidates.

Authors:  Monica A McArthur; Marcelo B Sztein; Robert Edelman
Journal:  Expert Rev Vaccines       Date:  2013-08       Impact factor: 5.217

3.  Influence of demographics on clinical outcome of dengue: a cross-sectional study of 6703 confirmed cases in Vitória, Espírito Santo State, Brazil.

Authors:  C R Vicente; C Cerutti Junior; G Fröschl; C M Romano; A S A Cabidelle; K-H Herbinger
Journal:  Epidemiol Infect       Date:  2016-09-09       Impact factor: 4.434

4.  Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis.

Authors:  Maria Glória Teixeira; João Bosco Siqueira; Germano L C Ferreira; Lucia Bricks; Graham Joint
Journal:  PLoS Negl Trop Dis       Date:  2013-12-19

5.  Estimating Dengue Transmission Intensity from Case-Notification Data from Multiple Countries.

Authors:  Natsuko Imai; Ilaria Dorigatti; Simon Cauchemez; Neil M Ferguson
Journal:  PLoS Negl Trop Dis       Date:  2016-07-11

6.  Determination of clusters and factors associated with dengue dispersion during the first epidemic related to Dengue virus serotype 4 in Vitória, Brazil.

Authors:  Creuza Rachel Vicente; Karl-Heinz Herbinger; Crispim Cerutti Junior; Camila Malta Romano; Aline de Souza Areias Cabidelle; Günter Fröschl
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

7.  Linking mosquito surveillance to dengue fever through Bayesian mechanistic modeling.

Authors:  Clinton B Leach; Jennifer A Hoeting; Kim M Pepin; Alvaro E Eiras; Mevin B Hooten; Colleen T Webb
Journal:  PLoS Negl Trop Dis       Date:  2020-11-23

8.  Is pregnancy associated with severe dengue? A review of data from the Rio de Janeiro surveillance information system.

Authors:  Carolina Romero Machado; Elizabeth Stankiewicz Machado; Roger Denis Rohloff; Marina Azevedo; Dayse Pereira Campos; Robson Bruniera de Oliveira; Patrícia Brasil
Journal:  PLoS Negl Trop Dis       Date:  2013-05-09

Review 9.  Why are people with dengue dying? A scoping review of determinants for dengue mortality.

Authors:  Mabel Carabali; Libia Milena Hernandez; Maria Jose Arauz; Luis Angel Villar; Valéry Ridde
Journal:  BMC Infect Dis       Date:  2015-07-30       Impact factor: 3.090

10.  Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil.

Authors:  Gustavo H Dayan; Pedro Garbes; Fernando Noriega; Ana Daniela Izoton de Sadovsky; Patricia Marques Rodrigues; Camila Giuberti; Reynaldo Dietze
Journal:  Am J Trop Med Hyg       Date:  2013-11-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.